Design, Synthesis, and Biological Evaluation of New 2,6,7-Substituted Purine Derivatives as Toll-like Receptor 7 Agonists for Intranasal Vaccine Adjuvants
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Morgan Kim und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea. Hauptthemen laut MEDLINE: Toll-Like Receptor 7, Administration, Intranasal, Drug Design, Influenza Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Korea Health Industry Development Institute, Korea Research Institute of Chemical Technology, National Research Foundation of Korea.
Abstract (Originalsprache)
TLR7/8 agonists are versatile immune stimulators capable of treating various diseases such as viral infections, autoimmune, and cancer. Despite the structural similarity of TLR7/8, their immune stimulation mechanisms and time-course responses significantly differ. In this study, a new series of TLR7-selective agonists was synthesized utilizing the economical building block 2,6-dichloropurine. Compound 27b showed the most potent activity on hTLR7 with an EC50 of 17.53 nM and demonstrated high hTLR7 selectivity (224 folds against TLR8). 27b effectively stimulated the secretion of proinflammatory cytokines in mouse macrophages and enhanced intranasal vaccine efficacy against influenza A virus in vivo. Assessment of humoral and mucosal antibody titers confirmed that 27b elevates IgG and IgA levels, protecting against both homologous and heterologous influenza viral infections. These findings suggest that 27b is a promising candidate as a vaccine adjuvant to prevent viral infections or as a robust immunomodulator with prolonged activity for treating immune-suppressed diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.
- Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea.
- Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon 34134, Republic of Korea.
- JD Bioscience, 208 Cheomdan-gwagiro, Buk-gu, Gwangju 61005, Republic of Korea.
- Medicinal Chemistry and Pharmacology, University of Science and Technology, Daejeon 34113, Republic of Korea.
- Bio and Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.
ORCID-Profile: Morgan Kim, Jun-Ho Choi, Soo Bong Han, Seong Soon Kim, Meehyein Kim, Jin Hee Ahn
Förderung
- Korea Health Industry Development Institute
- Korea Research Institute of Chemical Technology
- National Research Foundation of Korea
- Korea Institute of Energy Technology Evaluation and Planning
Zitieren
APA
Kim, M., Noh, K., Kim, P., Kim, J. H., Choi, B. W., Singh, R., Choi, J. H., Han, S. B., Kim, S. S., Lee, E. Y., Bae, M. A., Shin, D., Kim, M., & Ahn, J. H. (2024). Design, Synthesis, and Biological Evaluation of New 2,6,7-Substituted Purine Derivatives as Toll-like Receptor 7 Agonists for Intranasal Vaccine Adjuvants. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00489
Vancouver
Kim M, Noh K, Kim P, Kim JH, Choi BW, Singh R, et al. Design, Synthesis, and Biological Evaluation of New 2,6,7-Substituted Purine Derivatives as Toll-like Receptor 7 Agonists for Intranasal Vaccine Adjuvants. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00489
BibTeX
@article{Kim2024,
author = {Kim, Morgan and Noh, Kyungseob and Kim, Pyeongkeun and Kim, Jae Ho and Choi, Byeong Wook and Singh, Ravi and Choi, Jun-Ho and Han, Soo Bong and Kim, Seong Soon and Lee, Eun-Young and Bae, Myung Ae and Shin, Daeho and Kim, Meehyein and Ahn, Jin Hee},
title = {Design, Synthesis, and Biological Evaluation of New 2,6,7-Substituted Purine Derivatives as Toll-like Receptor 7 Agonists for Intranasal Vaccine Adjuvants},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00489}
}
EUVIMED